Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - GAMG [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - hTERT-RPE1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - JURKAT [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - OE19 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - SuSa [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"	"Single Cell Type RNA - Alveolar cells type 1 [NX]"	"Single Cell Type RNA - Alveolar cells type 2 [NX]"	"Single Cell Type RNA - B-cells [NX]"	"Single Cell Type RNA - Basal glandular cells [NX]"	"Single Cell Type RNA - Basal keratinocytes [NX]"	"Single Cell Type RNA - Bipolar cells [NX]"	"Single Cell Type RNA - Cardiomyocytes [NX]"	"Single Cell Type RNA - Cholangiocytes [NX]"	"Single Cell Type RNA - Ciliated cells [NX]"	"Single Cell Type RNA - Club cells [NX]"	"Single Cell Type RNA - Collecting duct cells [NX]"	"Single Cell Type RNA - Cone photoreceptor cells [NX]"	"Single Cell Type RNA - Cytotrophoblasts [NX]"	"Single Cell Type RNA - Distal tubular cells [NX]"	"Single Cell Type RNA - Ductal cells [NX]"	"Single Cell Type RNA - Early spermatids [NX]"	"Single Cell Type RNA - Endothelial cells [NX]"	"Single Cell Type RNA - Enterocytes [NX]"	"Single Cell Type RNA - Erythroid cells [NX]"	"Single Cell Type RNA - Exocrine glandular cells [NX]"	"Single Cell Type RNA - Extravillous trophoblasts [NX]"	"Single Cell Type RNA - Fibroblasts [NX]"	"Single Cell Type RNA - Glandular cells [NX]"	"Single Cell Type RNA - granulocytes [NX]"	"Single Cell Type RNA - Hepatocytes [NX]"	"Single Cell Type RNA - Hofbauer cells [NX]"	"Single Cell Type RNA - Horizontal cells [NX]"	"Single Cell Type RNA - Intestinal endocrine cells [NX]"	"Single Cell Type RNA - Ito cells [NX]"	"Single Cell Type RNA - Kupffer cells [NX]"	"Single Cell Type RNA - Late spermatids [NX]"	"Single Cell Type RNA - Leydig cells [NX]"	"Single Cell Type RNA - Macrophages [NX]"	"Single Cell Type RNA - Melanocytes [NX]"	"Single Cell Type RNA - monocytes [NX]"	"Single Cell Type RNA - Mucus-secreting cells [NX]"	"Single Cell Type RNA - Muller glia cells [NX]"	"Single Cell Type RNA - Pancreatic endocrine cells [NX]"	"Single Cell Type RNA - Paneth cells [NX]"	"Single Cell Type RNA - Peritubular cells [NX]"	"Single Cell Type RNA - Proximal tubular cells [NX]"	"Single Cell Type RNA - Rod photoreceptor cells [NX]"	"Single Cell Type RNA - Sertoli cells [NX]"	"Single Cell Type RNA - Smooth muscle cells [NX]"	"Single Cell Type RNA - Spermatocytes [NX]"	"Single Cell Type RNA - Spermatogonia [NX]"	"Single Cell Type RNA - Suprabasal keratinocytes [NX]"	"Single Cell Type RNA - Syncytiotrophoblasts [NX]"	"Single Cell Type RNA - T-cells [NX]"	"Single Cell Type RNA - Undifferentiated cells [NX]"	"Single Cell Type RNA - Urothelial cells [NX]"
AC093827.5		ENSG00000285458	"Uncharacterized protein C4orf36 "	Q96KX1	4	86886472-86936178	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"	18	"Alveolar cells type 1: 11.9;Ciliated cells: 14.7;Club cells: 3.4;Distal tubular cells: 5.0"									"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 12.2"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"																		2.0	2.0	4.4	0.9	8.1	1.5	3.4	1.0	4.5	2.0	1.3	9.7	2.2	1.6	1.8	3.7	2.2	1.6	1.1	6.8	4.6		3.0	0.8	1.5	0.3	8.9	3.7	1.8	1.2	3.3	1.6	1.6	5.8	2.5	1.8	2.6	2.0	2.4	4.8	5.1	1.6	3.0	8.9	1.2	2.1	3.2	8.2	0.0	3.9	2.4	0.3	1.6	0.0	2.0	2.8	3.3	1.8	2.0	3.1	0.6	2.9	1.8	0.9	1.3	2.8	2.5	1.4	2.7	2.8	0.9	1.4	1.3	4.9	0.5	2.5	1.8	2.3	2.0	1.3	1.6	1.1	2.3	1.0	2.3	2.2	1.3	1.6	3.6	1.5	1.7	4.2	0.9	3.2	1.5	0.8	1.2	1.6	12.2	0.5	0.9	1.5	1.4	2.1	2.8	1.2	2.9	1.2	2.6	2.9	2.1	1.0	1.8	2.1	2.1	2.4	1.4	3.8	2.6	1.0	2.3	3.1	1.0	1.6	4.4	2.0	4.0	1.9	1.7	1.2	1.6	1.7	1.5	2.0	1.8	2.5	1.6	1.4	2.0	1.5	2.0	1.9	3.1	3.3	2.0	1.3	2.8	0.7	0.6											11.9	1.9	0.0	0.0	0.0	0.0	0.0	0.0	14.7	3.4	0.0	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASAH2		ENSG00000188611	"N-acylsphingosine amidohydrolase 2"	Q9NR71	10	50182778-50248610	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"intestine: 43.9"	"Cell type enhanced"	"Detected in many"	9	"Late spermatids: 6.0;Muller glia cells: 10.2;Sertoli cells: 6.5"	"Low cancer specificity"	"Detected in single"							"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"											HPA061171	Supported		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA		1200000	"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (3.59e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.66e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.33e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.64e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.02e-3)"	0.3	1.1	0.6	0.2	0.9	0.0	0.5	0.5	1.3	1.7	0.5			43.9	0.7	0.3	0.7	0.5	0.2	0.9	0.5	1.4	0.6	1.6	0.4	0.2	1.2		1.4	1.5	0.3	1.0	0.4		0.5	0.3		0.9	0.2	0.8	0.7	33.4	0.7	0.6	0.2	2.5	1.1			0.6		0.1	1.0	0.5	0.9	0.9	0.0	0.0	0.0	2.2	0.1	1.8	1.4	1.6	2.2	2.9	1.1	2.0	2.0	1.3	3.8	3.5	1.0	4.6	0.0	2.2	2.7	3.1	1.7	2.1	0.7	4.7	2.3	3.8	1.3	3.8	2.9	1.8	0.4	0.2	0.4	2.6	6.6	7.5	0.5	0.8	0.0	2.5	1.2	2.5	1.5	1.4	0.1	4.8	0.0	4.1	0.0	6.4	1.6	2.1	0.3	2.7	7.3	2.5	1.8	3.3	3.9	1.5	1.0	2.0	1.9	4.4	4.7	6.1	1.9	0.2	0.0	5.5	0.0	1.7	0.0	0.0	0.0	0.7	0.0	2.2	0.9	0.4	1.7	0.0	0.1	1.4	2.1	0.0	0.0	0.0	0.9	0.6	0.1											0.0	0.0	0.0	0.2	0.3	1.8	3.0	0.0	0.0	1.2	0.0	2.0	0.3	0.0	1.1	4.1	0.1	1.3	0.0	1.3	0.2	0.4	0.2	0.0	1.8	0.2	1.6	0.0	0.6	0.0	6.0	1.1	0.0	0.0	0.0	1.2	10.2	1.4	0.0	1.4	0.6	1.8	6.5	0.9	0.9	0.8	0.1	0.2	0.0	0.6	0.1
ASAH2B	"ASAH2C, ASAH2L, bA449O16.3, bA98I6.3"	ENSG00000204147	"N-acylsphingosine amidohydrolase 2B"	P0C7U1	10	50739318-50816495	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in all"		"intestine: 27.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 19.2"									HPA061171	Supported		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA061171: AB_2684442"	"unprognostic (6.86e-3)"	"unprognostic (1.91e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.42e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.79e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.46e-1)"	2.8	8.3	6.5	3.3	10.7	2.3	4.6	4.4	14.5	4.0	4.5	1.5	3.8	27.5	5.1	6.2	4.4	4.8	4.3	7.8	7.2	9.0	7.3	12.2	3.7	2.9	5.7	8.3	5.6	7.6	8.8	12.8	2.1	7.4	6.3	5.3	7.0	6.6	4.4	5.7	3.0	16.0	4.4	3.9	3.0	6.4	5.2	2.0	2.7	5.6	6.8	4.8	3.8	3.4	1.4	3.2	0.5	0.1	0.7	6.0	1.5	1.9	2.0	3.1	5.2	1.1	2.6	2.5	9.7	5.3	5.9	4.9	6.8	4.9	0.1	3.7	2.1	2.0	2.0	3.6	4.1	4.8	3.7	4.0	1.3	5.8	4.5	3.9	1.7	1.9	3.3	4.8	5.6	8.7	1.9	1.2	0.0	6.2	2.5	4.8	4.3	2.8	0.2	4.0	5.5	19.2	0.1	7.3	2.4	3.5	7.2	6.0	12.1	3.3	4.1	3.4	3.5	6.9	1.2	6.4	2.5	11.6	5.3	11.4	3.0	0.4	0.0	12.8	0.0	4.3	0.5	0.1	0.0	2.2	0.0	6.0	0.7	3.5	2.5	0.0	1.4	4.9	4.5	0.4	0.7	0.1	3.2	3.9	1.5	6.5	10.7	4.4	14.5	7.2	9.0	5.7	8.3	7.4	2.0	3.0	0.6	0.5	0.8	1.4	5.5	4.9	2.5	1.4	1.2	5.2	7.9	1.3	5.0	4.1	0.1	1.5	2.0	0.0	4.1	1.2	1.8	1.1	0.0	6.8	0.3	0.0	6.4	1.8	0.0	0.8	1.7	0.0	1.7	0.0	5.1	4.0	3.3	3.4	1.1	4.1	4.4	0.0	2.1	3.7	1.8	0.4	0.5	2.2	4.1	0.8
ASB16	FLJ30165	ENSG00000161664	"Ankyrin repeat and SOCS box containing 16"	Q96NS5	17	44170447-44179083	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 38.4;tongue: 17.6"	"Cell type enhanced"	"Detected in some"	13	"Horizontal cells: 1.6;Ito cells: 1.3;Rod photoreceptor cells: 2.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	13	"cerebellum: 11.4"	"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 12.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA066834	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA066834: AB_2685732"	"unprognostic (2.72e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.03e-2)"	"unprognostic (6.13e-2)"	"unprognostic (7.23e-4)"	"unprognostic (5.84e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.53e-3)"	"unprognostic (7.33e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.07e-3)"	0.9	0.6	0.2	1.3	0.3	1.2	0.5	11.4	0.7	0.6	1.2	0.3	0.9	1.3	1.3	1.9	1.1	1.0	0.6	12.6	0.7	0.4	0.8	0.4	0.7	1.9	0.6	0.2	1.1	7.0	1.6	1.8	0.3	0.8	1.7	0.0	2.7	1.2	0.1	38.4	1.9	1.3	4.1	0.2	1.8	1.3	0.6	0.3	0.0	0.9	17.6	1.1	1.6	1.5	4.4	2.9	9.6	2.4	4.0	4.5	2.7	2.1	4.1	4.9	4.6	0.0	0.0	4.0	4.5	0.0	0.0	0.0	3.1	2.4	3.3	2.8	0.0	1.0	5.1	0.0	0.0	0.0	5.1	7.3	2.1	7.1	3.4	0.0	2.2	6.6	0.0	0.0	0.0	0.0	1.3	0.0	5.0	3.8	8.3	0.0	3.5	2.6	4.1	1.5	0.8	4.9	8.3	4.8	4.9	0.0	3.3	5.1	2.8	2.1	0.6	0.7	1.5	6.4	2.1	2.2	6.2	5.7	3.8	2.8	12.7	6.2	3.1	1.4	3.2	4.1	4.0	2.4	9.6	3.1	2.2	3.7	4.4	3.3	3.0	1.2	3.8	4.5	2.8	7.3	4.0	1.9	2.9	3.2	2.7	0.2	0.3	11.4	0.6	0.7	0.4	0.6	0.2	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0
BTBD7	"FLJ10648, FUP1"	ENSG00000011114	"BTB domain containing 7"	Q9P203	14	93237550-93333092	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049926, HPA053406"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA049926: AB_2680956, HPA053406: AB_2682137"	"unprognostic (3.36e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.74e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.97e-3)"	"unprognostic (4.34e-2)"	"prognostic favorable (1.69e-6)"	"unprognostic (7.27e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-2)"	"unprognostic (9.52e-2)"	11.1	8.4	10.2	11.0	11.6	11.8	9.9	14.1	11.6	11.9	10.4	14.3	10.9	8.2	11.4	8.0	13.2	10.9	10.8	9.6	8.9	5.4	13.3	8.7	10.6	7.5	10.1	7.8	11.6	10.1	26.1	10.2	18.0	10.3	9.2	10.5	8.0	10.8	10.3	13.0	11.3	12.0	11.0	7.4	9.5	8.9	20.0	10.7	9.1	15.4	6.7	9.1	13.5	15.5	1.6	1.7	4.4	1.3	0.5	1.5	0.2	7.5	5.8	7.3	3.9	5.8	7.7	10.5	6.7	6.6	6.0	4.7	5.2	6.5	3.9	5.2	9.9	4.4	7.3	7.1	14.9	10.1	4.6	3.1	4.1	4.4	3.8	2.9	7.0	4.7	6.4	4.6	7.4	8.7	5.4	9.4	3.0	3.9	5.1	8.6	6.7	2.8	2.0	4.7	5.4	7.5	8.0	10.9	1.9	9.2	25.1	9.2	5.6	7.4	3.4	3.2	7.7	6.8	4.8	12.6	5.8	5.6	5.3	5.0	4.0	3.4	4.7	5.2	3.6	6.8	3.1	0.7	4.4	1.4	0.7	0.4	1.5	1.0	1.3	0.6	1.6	0.9	1.0	1.8	0.5	1.3	1.7	1.5	0.2	10.2	11.6	14.1	11.6	8.9	5.4	10.1	7.8	10.3	10.7	47.6	23.0	18.2	23.5	28.7	25.9	17.8	33.1	18.7	14.8	52.4	35.3	18.3	11.6	27.9	34.8	35.0	22.6	0.0	21.2	18.5	27.2	36.7	24.3	15.1	15.3	25.4	27.6	43.6	27.3	37.7	21.9	21.1	10.1	33.3	22.7	29.5	33.2	23.0	37.1	32.3	29.0	12.9	43.2	24.5	32.1	32.2	25.6	19.8	24.7	62.6
C4orf36	MGC26744	ENSG00000163633	"Chromosome 4 open reading frame 36"	Q96KX1	4	86876205-86892422	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"testis: 14.0"	"Group enriched"	"Detected in many"	11	"Early spermatids: 140.3;Late spermatids: 253.3"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basal ganglia: 1.8;cerebral cortex: 1.6;hippocampal formation: 3.3;pons and medulla: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.8;CAPAN-2: 4.6;hTCEpi: 3.8;hTERT-HME1: 5.5"									HPA057434	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057434: AB_2683438"	"unprognostic (2.01e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.76e-2)"	"unprognostic (7.31e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.93e-3)"	"unprognostic (2.39e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.55e-1)"	"prognostic favorable (7.69e-5)"	"unprognostic (2.85e-1)"	"unprognostic (2.44e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.75e-2)"	0.6	0.2	0.1	0.7	1.8	0.0	2.1	0.4	1.6	1.7	0.3	0.7	0.0	0.3	1.0	0.4	1.0	0.4	0.0	1.4	3.3	0.2	0.6	0.5	0.9	0.0	0.2	0.4	1.7	0.5	0.0	2.6	0.2	1.4	1.3	0.3	0.1	0.6	0.3	0.1	4.2	0.1	0.6	0.3	0.8	0.2	14.0	0.0	0.0	0.8	0.0	0.4	0.5	0.8	0.1	0.9	0.3	0.0	0.0	0.1	0.0	5.8	0.5	0.3	0.2	0.0	0.3	1.2	2.9	0.8	0.7	0.0	0.3	4.6	0.0	0.5	0.0	0.1	2.6	0.4	2.6	0.7	0.1	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	3.8	0.0	5.5	0.1	0.0	0.2	0.4	0.1	0.0	2.7	1.8	0.2	0.8	1.2	0.0	1.4	0.0	0.0	0.9	2.4	0.7	1.8	0.8	0.4	0.0	0.5	1.1	0.0	0.0	0.6	1.0	0.3	0.4	0.2	0.9	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.8	0.4	1.6	3.3	0.2	0.2	0.4	1.4	0.0	0.0	0.0	3.4	9.5	4.4	4.8	18.1	12.7	0.0	0.0	0.0	9.8	0.9	0.0	0.0	140.3	7.1	10.2	0.0	0.0	1.6	3.8	3.9	0.0	2.4	2.8	1.6	2.9	4.3	5.4	253.3	4.9	1.5	1.7	0.0	7.4	6.3	0.3	9.3	3.2	0.0	6.8	6.5	3.1	3.7	7.0	8.9	8.1	2.2	5.2	3.9
CEP135	"CEP4, FLJ13621, KIAA0635"	ENSG00000174799	"Centrosomal protein 135"	Q66GS9	4	55948871-56033363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"			"Mental retardation, Primary microcephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 27.1"	"Cell type enhanced"	"Detected in all"	6	"Early spermatids: 56.2;monocytes: 85.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073950			Uncertain	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA073950: "	"unprognostic (2.75e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.63e-1)"	"unprognostic (3.42e-2)"	"unprognostic (4.65e-3)"	"unprognostic (4.78e-3)"	"unprognostic (1.83e-3)"	"unprognostic (9.89e-3)"	"unprognostic (9.50e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.02e-9)"	"unprognostic (7.55e-2)"	"unprognostic (5.54e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (6.11e-5)"	5.5	3.0	2.9	13.8	6.0	12.8	5.2	5.1	5.3	8.5	4.6	3.1	7.5	4.3	12.8	4.5	4.7	7.4	4.5	3.4	5.3	3.4	5.7	2.9	7.0	13.0	5.8	3.9	9.6	4.5	4.1	6.9	8.1	4.5	4.4	4.6	2.5	3.7	5.9	2.3	5.4	6.2	7.1	5.5	11.1	3.6	9.3	4.6	27.1	5.0	4.5	10.1	4.8	5.6	9.2	8.7	11.9	4.4	7.1	7.5	2.0	6.9	3.8	10.7	10.0	2.2	4.3	4.6	6.9	4.9	6.4	7.5	4.3	7.3	18.9	5.3	3.1	5.1	3.3	11.1	4.3	12.1	5.1	7.1	6.6	5.7	3.8	2.4	11.9	10.4	3.3	3.4	8.0	5.8	2.9	5.3	9.7	12.1	9.1	6.5	4.2	16.6	7.4	6.7	3.5	4.2	12.1	5.1	3.9	4.6	5.2	7.7	8.1	6.2	4.2	5.1	6.7	5.7	7.7	5.2	8.7	14.2	10.3	12.1	5.0	3.5	12.9	4.4	9.4	10.6	11.9	3.4	4.2	4.7	4.1	4.3	4.6	6.0	4.5	2.1	9.2	7.5	4.8	7.0	7.1	4.4	8.7	3.7	2.0	2.9	6.0	5.1	5.3	5.3	3.4	5.8	3.9	4.5	4.6	6.0	14.3	15.9	7.2	8.0	12.6	7.3	2.5	22.7	14.8	7.0	9.8	15.3	3.3	7.8	56.2	15.3	3.9	23.3	4.7	11.7	5.9	4.3	13.9	1.8	9.0	25.4	5.2	12.3	9.2	11.4	5.5	17.8	5.0	85.6	4.3	4.7	11.0	5.7	7.8	9.0	21.0	6.5	6.6	53.2	43.8	5.8	8.0	16.0	5.2	5.5
CPAMD8	"K-CAP, KIAA1283, VIP"	ENSG00000160111	"C3 and PZP like, alpha-2-macroglobulin domain containing 8"	Q8IZJ3	19	16892947-17026815	"Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 19.3;retina: 23.7;seminal vesicle: 30.5"	"Cell type enhanced"	"Detected in many"	6	"Alveolar cells type 1: 20.8;Alveolar cells type 2: 21.4;Collecting duct cells: 26.2;Glandular cells: 18.0;Leydig cells: 29.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"classical monocyte: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"BEWO: 14.7;EFO-21: 9.5;T-47d: 25.8"					"Not detected"	"Not detected"			"HPA031327, HPA031328, HPA031329, HPA031330"	Uncertain		Uncertain	"Focal adhesion sites"	"Secreted to blood"	NA	NA		180000	"Focal adhesion sites"		"HPA031327: AB_2673829, HPA031328: AB_2673830, HPA031329: , HPA031330: AB_10603788"	"unprognostic (4.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.76e-2)"	"unprognostic (4.32e-2)"	"unprognostic (4.06e-3)"	"unprognostic (7.85e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.24e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.80e-2)"	3.1	1.3	1.0	0.4	2.3	0.2	3.6	0.6	2.3	5.3	0.4	2.9	6.5	0.2	1.5	8.2	0.6	0.6	0.4	7.0	1.2	1.3	8.9	0.5	11.5	1.5	4.9	0.4	0.6	0.4	3.5	2.0	3.1	5.1	19.3	0.0	23.7	1.1	30.5	1.7	0.4	0.4	0.4	5.6	1.1	0.1	0.9	2.8	0.9	11.6	1.4	0.4	1.2	1.4	0.2	0.0	0.6	1.5	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	14.7	0.0	0.1	0.0	0.0	0.0	0.0	0.3	9.5	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	2.2	0.5	0.0	0.0	1.4	0.0	0.1	0.4	2.0	0.0	0.0	0.0	0.4	0.0	0.1	25.8	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.5	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	2.3	0.6	2.3	1.2	1.3	4.9	0.4	5.1	2.8	20.8	21.4	0.0	10.1	0.8	0.4	4.8	2.5	1.4	12.5	26.2	0.0	6.4	0.0	0.6	1.5	8.6	0.0	0.0	0.0	5.0	2.4	18.0	2.3	0.0	2.6	0.0	0.0	12.9	6.6	3.6	29.1	1.5	0.0	0.0	0.4	0.0	0.9	0.8	6.0	0.0	0.0	0.0	2.8	5.4	1.0	0.5	5.0	0.0	0.0	3.4
DOK5	"C20orf180, dJ805C22.1"	ENSG00000101134	"Docking protein 5"	Q9P104	20	54475597-54651171	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"skeletal muscle: 41.3"	"Cell type enhanced"	"Detected in many"	10	"Distal tubular cells: 33.2;Horizontal cells: 36.5;monocytes: 25.2;Muller glia cells: 60.0"	"Group enriched"	"Detected in many"	6	"glioma: 18.0;ovarian cancer: 29.4"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 19.7;ASC diff: 8.0;ASC TERT1: 6.8;hTEC/SVTERT24-B: 8.2;U-138 MG: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054460, HPA065235"	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA054460: AB_2682495, HPA065235: AB_2685441"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (8.99e-7)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.88e-4)"	"unprognostic (5.12e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.49e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.08e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.99e-2)"	3.5	2.7	15.5	2.3	11.0	0.6	2.0	1.4	14.8	1.8	1.3	6.6	0.4	1.0	2.1	1.0	2.4	13.6	10.6	18.1	11.0	12.5	3.6	3.2	1.0	1.2	8.4	6.2	2.4	1.9	0.9	1.2	2.4	7.3	1.6	1.4	7.6	1.7	1.5	41.3	0.6	1.1	3.5	5.4	0.9	0.9	2.2	6.4	0.0	5.9	6.4	1.0	3.6	3.5	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	19.7	0.0	8.0	6.8	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	2.6	0.0	8.2	0.0	0.3	1.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	2.0	4.2	0.0	5.2	0.0	0.0	0.0	0.2	1.2	0.0	0.0	0.0	31.2	2.0	0.9	0.0	0.0	0.0	0.1	1.4	0.0	2.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	11.0	1.4	12.6	11.0	12.5	8.4	6.2	7.3	6.4	0.0	0.0	0.0	1.0	0.2	9.7	5.9	17.8	0.0	0.0	10.4	5.9	0.2	33.2	16.2	1.9	2.3	0.0	0.0	1.0	0.5	11.2	0.9	0.0	0.0	21.8	36.5	0.0	9.8	0.3	3.1	2.3	1.1	0.0	25.2	0.0	60.0	3.5	0.0	1.1	0.0	7.4	0.0	2.0	0.6	0.4	0.4	0.7	0.0	0.0	0.4
EMC4	"FLJ90746, MGC24415, PIG17, TMEM85"	ENSG00000128463	"ER membrane protein complex subunit 4"	Q5J8M3	15	34224999-34230156	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026868, HPA053440"	Approved		Supported	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA026868: AB_2672032, HPA053440: AB_2682151"	"unprognostic (8.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.97e-2)"	36.3	34.3	43.5	23.4	48.3	25.4	35.2	34.9	54.3	33.5	32.2	31.0	25.7	27.5	33.5	54.3	36.2	35.4	28.4	38.5	39.4	40.6	39.1	47.5	27.1	24.5	41.7	42.8	35.3	45.2	29.1	29.5	41.5	48.6	32.5	30.1	32.8	38.9	34.7	95.1	29.6	27.9	30.1	36.7	27.2	31.2	26.4	32.0	26.9	34.6	41.2	29.0	28.9	32.6	71.6	53.3	65.7	59.4	60.3	65.9	78.0	31.9	67.2	28.3	36.6	36.9	33.6	26.0	36.7	42.2	45.4	39.5	43.7	28.5	12.7	48.6	42.4	39.9	61.6	28.7	36.0	32.6	38.7	27.8	24.0	62.0	40.1	44.7	36.3	24.1	33.7	34.4	33.0	37.2	32.4	37.5	38.9	29.9	50.6	39.5	36.4	28.8	38.9	31.7	43.2	44.1	26.7	25.8	35.9	43.2	50.4	37.3	45.6	27.3	40.1	19.4	21.5	26.8	43.2	28.5	41.7	28.6	35.8	37.3	44.9	63.5	32.4	50.8	43.4	35.2	65.7	52.3	54.5	53.0	54.0	57.9	71.6	59.5	63.4	52.2	54.6	60.8	59.8	29.1	60.3	59.4	53.3	65.9	78.0	43.5	48.3	34.9	54.3	39.4	40.6	41.7	42.8	48.6	32.0	50.6	63.2	53.6	84.9	81.4	33.7	52.6	50.9	116.4	81.9	62.8	17.7	127.8	106.1	146.0	74.2	81.8	39.4	0.0	149.7	140.0	89.5	80.2	84.5	75.5	101.4	17.5	50.0	54.0	38.3	16.6	93.2	68.5	96.2	106.4	60.1	89.7	146.5	66.8	85.2	85.7	30.5	84.1	115.4	137.4	96.5	96.1	118.5	65.3	63.0	96.2
GUCA1C	GCAP3	ENSG00000138472	"Guanylate cyclase activator 1C"	O95843	3	108907792-108953895	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	4	"heart muscle: 10.2;pancreas: 31.0;retina: 15.7"	"Cell type enriched"	"Detected in some"	6	"Cone photoreceptor cells: 117.8"	"Cancer enriched"	"Detected in single"	7	"pancreatic cancer: 0.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	84	"RPTEC TERT1: 18.0"									HPA041597	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA041597: AB_10795501"						"unprognostic (7.56e-2)"					"unprognostic (6.56e-2)"							0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.7	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.7	31.0	0.0	0.2	0.0	0.5	0.0	0.0	15.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.7	0.0	0.0	0.0	0.0	0.0	2.8	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	0.7	0.0	0.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	7.4	5.5	0.0	0.0	0.0	0.0	117.8	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	8.2	0.5	0.0	0.0	0.0	19.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0
IGFLR1	"FLJ22573, TMEM149, U2AF1L4"	ENSG00000126246	"IGF like family receptor 1"	Q9H665	19	35738801-35742453	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 121.2;liver: 46.2;lymphoid tissue: 40.7"	"Cell type enriched"	"Detected in many"	5	"monocytes: 187.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"plasmacytoid DC: 121.2"	"Lineage enriched"	"Detected in all"	4	"dendritic cells: 121.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 22.3;Karpas-707: 17.1;U-266/70: 22.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA012369	Uncertain		Approved	"Focal adhesion sites"	"Intracellular and membrane"	NA	NA			"Focal adhesion sites"		"HPA012369: AB_1858095"	"unprognostic (5.97e-3)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.94e-1)"	"unprognostic (5.42e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.34e-4)"	"unprognostic (6.71e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (1.59e-5)"	"unprognostic (1.44e-3)"	"unprognostic (3.52e-1)"	"unprognostic (8.72e-12)"	"unprognostic (2.74e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.32e-3)"	5.3	7.3	4.5	17.8	7.6	10.1	4.1	2.0	5.3	3.1	5.0	3.8	0.0	5.6	2.6	4.7	3.4	4.5	5.9	5.8	4.5	3.1	17.0	46.2	8.5	40.7	7.7	1.6	4.5	6.9	1.1	3.4	3.8	5.6	4.0	5.4	2.2	7.4	1.8	3.9	4.6	8.4	3.5	5.4	20.2	6.3	3.5	4.5	14.6	10.0	3.2	19.3	8.0	4.9	22.3	121.2	28.6	26.5	18.1	17.4	16.3	1.3	6.5	2.3	5.4	0.8	1.2	1.3	1.5	0.7	1.2	3.1	1.9	1.6	2.8	2.1	0.4	0.4	1.0	1.3	1.3	0.6	2.1	3.3	10.0	2.7	6.8	1.9	1.3	22.3	1.8	0.8	2.3	0.5	0.9	1.2	5.0	3.0	17.1	0.3	5.5	3.1	10.5	1.6	5.9	1.7	3.8	2.2	5.2	1.1	2.4	1.6	3.1	2.1	1.5	1.1	1.1	2.4	5.4	0.3	2.8	1.3	1.7	2.5	22.5	4.7	1.7	3.3	3.8	2.1	16.2	26.5	23.6	13.3	22.2	15.2	22.3	15.4	12.6	33.9	21.8	13.9	11.1	28.6	18.1	15.5	121.2	17.4	16.3	4.5	7.6	2.0	5.3	4.5	3.1	7.7	1.6	5.6	4.5	0.0	15.7	9.9	0.3	0.6	0.2	0.6	2.5	6.7	9.1	0.0	0.0	0.4	1.7	1.6	0.0	0.5	0.8	0.0	3.6	1.5	0.7	0.3	38.1	16.4	13.3	0.0	2.9	2.5	14.3	0.2	0.0	28.0	5.0	187.6	1.7	1.2	1.5	0.0	0.0	4.4	0.1	0.0	0.9	0.5	0.5	0.6	0.2	8.5	1.2	0.0
IGSF5	JAM4	ENSG00000183067	"Immunoglobulin superfamily member 5"	Q9NSI5	21	39745407-39802096	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"heart muscle: 5.8"	"Cell type enriched"	"Detected in some"	9	"Syncytiotrophoblasts: 95.4"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.3"					"Cell type enriched"	"Detected in single"	5	"neutrophil: 2.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"T-47d: 10.8"					"Low region specificity"	"Detected in all"			HPA057282	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA057282: AB_2683395"	"unprognostic (1.06e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.06e-2)"	"unprognostic (9.73e-5)"	"unprognostic (1.56e-2)"	"unprognostic (3.15e-1)"		"unprognostic (1.41e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.09e-1)"	"unprognostic (8.35e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.01e-1)"	"unprognostic (4.18e-1)"	"unprognostic (3.75e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.07e-2)"	0.0	2.0	0.9	0.0	3.4	0.1	1.3	0.1	0.7	1.1	0.3			0.2	0.9	3.4	0.0	0.9	0.3	5.8	1.2	2.3	0.3	0.3	0.1	0.2	1.3		1.5	2.5	0.3	1.5	4.3		2.4	0.9		0.9	0.4	0.0	0.6	0.1	0.4	0.7	0.3	0.6	1.5			0.8		0.2	0.5	0.2	0.4	0.3	2.2	0.4	0.0	0.4	0.0	1.3	0.7	4.5	1.1	4.4	3.6	1.2	0.8	1.2	1.3	2.0	0.7	1.3	1.4	1.2	1.7	1.7	1.2	1.5	3.0	2.5	2.3	2.1	1.4	3.3	0.5	2.8	1.9	0.6	3.2	5.5	2.9	3.2	2.2	0.6	0.7	2.6	0.9	1.7	1.6	0.3	0.6	2.5	1.1	0.8	0.7	2.0	0.8	1.9	1.9	2.0	0.5	1.2	3.0	1.8	2.1	10.8	1.1	0.4	2.0	2.3	1.0	1.8	1.0	0.8	0.9	1.1	1.4	2.0	0.1	0.4	0.4	0.4	0.0	0.2	0.1	0.3	0.1	0.1	0.4	0.1	0.2	2.2	0.0	0.1	0.3	0.0	0.0											0.0	0.0	0.0	0.2	0.0	1.3	8.7	0.0	0.0	0.0	1.8	0.0	0.9	5.0	0.3	11.1	0.0	0.0	0.0	0.2	0.9	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.4	2.7	0.1	0.0	0.2	0.5	0.1	0.0	95.4	0.0	0.0	0.9
LIMS2	"PINCH-2, PINCH2"	ENSG00000072163	"LIM zinc finger domain containing 2"	Q7Z4I7	2	127638381-127681786	"Disease related genes, Predicted intracellular proteins"			"Disease mutation, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 114.4"	"Cell type enhanced"	"Detected in many"	12	"Cardiomyocytes: 67.6;Endothelial cells: 62.4;Ito cells: 124.0;Peritubular cells: 46.7;Smooth muscle cells: 49.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"naive B-cell: 17.1"	"Group enriched"	"Detected in many"	14	"B-cells: 17.1;T-cells: 8.2"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.1;fHDF/TERT166: 13.2;HHSteC: 15.9;MOLT-4: 18.0;TIME: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058340	Enhanced		Supported	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA058340: AB_2683683"	"unprognostic (2.51e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.51e-2)"	"unprognostic (9.25e-2)"	"unprognostic (3.49e-1)"	"prognostic favorable (6.53e-7)"	"unprognostic (3.98e-2)"	"unprognostic (3.73e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.86e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.60e-3)"	"unprognostic (3.64e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.00e-2)"	21.9	4.4	3.4	16.7	4.5	0.2	17.9	1.5	5.8	31.7	83.5	4.6	18.1	6.5	49.9	17.4	28.3	23.8	31.8	40.2	4.2	1.8	11.7	8.0	20.1	4.9	3.7	4.3	8.2	2.9	2.6	2.8	11.6	6.4	30.6	6.6	20.4	8.0	45.1	12.5	5.7	16.9	114.4	4.0	21.6	25.6	6.8	2.7	11.5	9.3	6.5	4.5	65.1	44.9	17.1	0.8	0.3	0.2	0.0	8.2	1.9	0.3	0.7	0.2	0.0	2.1	0.5	0.2	8.8	12.1	9.4	8.8	2.3	0.0	0.0	5.1	13.2	0.5	0.0	0.1	0.0	2.0	0.0	0.3	0.0	5.6	1.6	15.9	0.0	0.0	0.1	0.0	3.6	0.1	5.2	6.6	7.2	0.0	0.0	4.4	0.0	18.0	0.4	0.6	0.0	1.1	4.1	0.8	0.4	0.6	0.0	0.0	0.1	1.6	0.8	0.3	3.3	0.3	0.0	37.8	0.0	6.4	8.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.1	0.0	0.1	0.2	0.0	10.7	3.9	0.8	0.1	17.1	8.2	3.3	0.3	0.0	0.1	0.8	5.2	1.9	3.4	4.5	1.5	5.8	4.2	1.8	3.7	4.3	6.4	2.7	20.8	9.6	4.9	0.2	8.4	0.0	67.6	2.5	1.4	2.3	0.0	0.0	0.5	0.0	0.8	1.3	62.4	0.0	0.0	0.2	10.4	16.2	0.1	2.3	14.0	0.9	0.0	0.0	124.0	7.2	1.4	18.4	3.4	10.1	0.0	0.0	0.1	0.7	0.0	46.7	0.0	1.0	25.8	49.1	0.5	1.4	5.8	0.8	1.3	0.0	0.3
MTSS1L	"ABBA, ABBA-1, LOC92154"	ENSG00000132613	"MTSS1L, I-BAR domain containing"	Q765P7	16	70661204-70686066	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 105.5"	"Cell type enhanced"	"Detected in many"	10	"Extravillous trophoblasts: 36.3;Hepatocytes: 24.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"MAIT T-cell: 2.4;plasmacytoid DC: 2.3"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 62.0;HHSteC: 61.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048531, HPA066469"	Approved		Supported	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA048531: AB_2680430, HPA066469: AB_2685671"	"prognostic unfavorable (2.85e-4)"	"unprognostic (8.85e-2)"	"unprognostic (7.01e-2)"	"unprognostic (5.99e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.59e-3)"	"unprognostic (3.88e-1)"	"unprognostic (2.92e-3)"	"unprognostic (9.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.25e-2)"	17.2	13.4	61.9	11.1	47.6	4.9	6.4	68.3	105.5	22.5	15.5	59.5	4.1	8.1	29.5	4.1	27.4	17.5	15.8	16.8	70.3	45.6	6.8	21.7	12.9	5.5	50.2	38.7	14.5	7.9	7.7	5.2	19.0	40.7	15.5	5.2	11.8	16.1	21.6	37.2	15.8	7.8	31.6	53.5	19.2	6.7	6.2	53.3	8.2	4.5	5.2	4.8	20.8	10.0	0.3	2.3	0.2	0.1	0.0	2.4	0.4	13.8	33.4	8.4	8.6	7.0	7.0	31.7	20.9	26.2	18.0	15.0	13.4	8.9	0.1	7.5	32.7	7.1	29.0	9.0	9.1	6.9	0.2	12.1	4.8	28.4	62.0	61.7	7.1	0.2	28.6	20.0	8.3	29.0	7.8	5.9	7.4	18.1	0.3	15.9	34.4	6.8	36.7	7.3	4.7	7.1	14.6	15.6	0.0	15.7	20.8	19.8	13.2	44.7	19.5	5.8	8.3	15.0	14.0	8.8	14.1	16.0	12.7	13.0	5.0	1.2	0.2	12.8	0.2	4.8	0.0	0.1	0.2	0.1	0.0	2.4	0.2	0.0	0.0	0.2	0.3	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.4	61.9	47.6	68.3	52.3	70.3	45.6	50.2	38.7	40.7	53.3	0.0	1.3	0.0	3.4	5.4	0.0	6.7	0.0	2.7	1.2	1.8	0.0	2.5	3.3	4.3	3.5	2.1	0.0	0.0	0.5	36.3	4.0	4.6	1.1	24.1	7.1	0.0	2.9	13.5	1.6	5.2	4.0	0.0	5.0	0.0	4.5	0.0	0.9	0.0	3.2	1.7	0.0	0.0	5.9	0.5	1.1	5.6	5.1	0.0	1.2	3.9
RAB24		ENSG00000169228	"RAB24, member RAS oncogene family"	Q969Q5	5	177301198-177303744	"Predicted intracellular proteins"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034945			Uncertain	"Focal adhesion sites"		No	No			"Focal adhesion sites"		"HPA034945: "	"unprognostic (1.03e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (6.22e-4)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.78e-2)"	"unprognostic (9.66e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (2.54e-7)"	"unprognostic (3.97e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.12e-2)"	13.6	19.7	18.3	19.9	20.9	24.6	16.8	25.0	24.2	12.1	13.7	7.5	25.3	15.3	10.9	23.6	21.0	11.9	12.4	12.7	15.4	18.0	16.6	15.2	14.2	15.5	13.1	22.0	16.9	31.4	16.2	26.0	15.6	19.8	15.3	11.0	14.1	23.2	20.8	27.1	19.5	15.6	14.5	10.6	27.6	12.8	5.7	13.1	5.9	18.8	15.1	19.9	11.0	15.9	7.5	14.5	38.0	42.0	7.9	5.1	10.2	2.9	7.9	5.2	10.4	8.5	7.5	10.9	9.1	11.4	11.3	13.7	9.5	3.9	3.2	11.2	7.2	12.6	2.8	7.0	9.8	6.3	55.2	5.6	11.0	8.0	8.1	17.9	6.9	10.0	12.4	8.0	12.0	8.5	16.7	6.9	8.8	8.2	17.5	7.9	11.2	2.5	19.9	3.3	5.9	8.0	1.5	8.6	12.4	7.6	5.2	6.7	9.1	2.8	5.6	23.5	6.6	10.1	17.4	7.6	4.0	6.5	9.1	7.8	13.4	6.3	4.1	7.5	11.2	8.4	8.7	21.4	38.0	5.1	42.0	4.4	7.5	2.5	4.2	14.5	6.8	2.8	4.4	33.0	7.9	40.7	3.2	2.1	10.2	18.3	20.9	25.0	24.2	15.4	18.0	13.1	22.0	19.8	13.1	3.0	10.3	9.9	1.7	4.7	3.1	2.0	0.0	4.0	10.3	1.8	2.0	6.2	3.3	21.3	0.3	4.2	15.7	0.0	17.6	4.6	4.4	1.9	11.5	1.5	3.9	12.7	17.3	8.0	10.0	0.2	4.6	9.1	3.3	1.0	12.6	1.9	16.4	15.2	1.1	5.4	4.4	0.0	4.1	2.4	3.3	5.3	25.6	4.9	12.8	2.0
RAPGEF4	"cAMP-GEFII, CGEF2"	ENSG00000091428	"Rap guanine nucleotide exchange factor 4"	Q8WZA2	2	172735274-173052893	"Predicted intracellular proteins"	Exocytosis	"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 29.6;brain: 70.9"	"Cell type enhanced"	"Detected in many"	12	"Cone photoreceptor cells: 43.2;Endothelial cells: 30.4;Ito cells: 23.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"amygdala: 68.3;basal ganglia: 31.5;cerebral cortex: 55.3;hippocampal formation: 70.9;olfactory region: 23.8"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 18.0;SCLC-21H: 7.0;U-266/70: 9.3;U-266/84: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004388, HPA028968"	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB004388: AB_670916, HPA028968: AB_2672846"	"unprognostic (1.87e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.98e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (6.32e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.93e-1)"	3.3	29.6	68.3	1.6	31.5	0.6	5.2	10.9	55.3	4.9	1.5	5.4	1.0	2.1	6.6	2.7	2.3	2.9	3.7	5.7	70.9	10.2	3.8	24.6	5.4	1.7	10.0	23.8	9.7	2.0	3.2	2.4	2.3	8.6	3.5	1.7	11.3	1.7	2.9	1.4	10.6	1.8	4.3	2.9	0.9	5.4	3.7	11.5	0.0	4.3	0.9	1.8	4.2	1.2	0.4	0.6	1.4	0.6	0.6	0.7	0.1	0.1	0.1	2.7	0.4	0.0	0.2	0.1	0.9	0.5	0.1	0.2	0.0	3.1	0.0	0.2	0.0	0.2	0.5	2.3	0.6	0.3	0.1	4.8	0.4	2.3	0.0	0.0	3.0	0.8	0.0	0.7	0.0	0.0	2.7	2.9	1.3	0.0	18.0	0.1	0.0	0.2	0.2	0.3	1.5	0.3	0.0	0.6	0.0	0.0	5.4	7.0	2.6	0.1	0.1	0.9	1.4	0.1	0.1	0.8	0.1	0.3	0.0	0.2	9.3	18.0	0.0	0.3	0.1	0.2	1.4	0.4	0.4	0.3	0.4	0.6	0.4	0.4	0.3	0.3	0.4	0.6	0.7	1.0	0.6	0.6	0.6	0.3	0.1	68.3	31.5	10.9	55.3	70.9	10.2	10.0	23.8	8.6	11.5	3.0	3.2	0.9	1.0	5.5	2.5	6.7	0.0	0.0	0.0	0.0	43.2	0.1	0.0	0.6	2.1	30.4	0.0	0.0	2.3	0.0	0.9	0.5	0.0	9.9	0.1	1.6	7.5	23.9	1.9	1.1	4.0	0.0	3.3	0.0	0.2	1.2	2.4	0.0	1.4	0.0	8.9	0.0	1.4	0.5	2.0	3.3	0.1	0.0	0.0	0.6
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 113.2;placenta: 228.8"	"Cell type enhanced"	"Detected in many"	9	"Cholangiocytes: 298.1;Hepatocytes: 520.4;Urothelial cells: 356.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	17	"memory B-cell: 3.9"	"Lineage enriched"	"Detected in single"	40	"B-cells: 3.9"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 62.1;hTCEpi: 57.5;U-251 MG: 59.2;U-266/70: 61.4;U-266/84: 129.2"	"Group enriched"	"Detected in some"	4	"cerebellum: 10.7;olfactory region: 5.9"	"Not detected"	"Not detected"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	1600000	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	0.8	3.4	0.5	5.4	0.6	0.0	4.5	0.8	0.7	21.4	18.3	0.5	3.5	14.3	2.3	8.7	103.7	1.6	55.3	0.3	0.4	0.5	68.5	113.2	15.8	6.3	1.9	0.4	1.6	7.0	0.6	0.6	228.8	0.7	13.3	6.2	1.5	16.0	5.2	0.5	69.5	21.9	4.3	0.4	3.7	16.3	2.6	0.4	1.5	3.5	62.3	48.4	30.0	37.7	3.9	0.0	0.0	0.0	0.0	0.0	0.5	31.4	17.6	5.6	14.0	1.5	0.2	17.7	8.8	8.5	8.2	7.0	3.7	19.2	0.0	3.2	6.2	4.5	31.1	2.4	62.1	5.5	0.1	1.6	0.0	1.6	18.8	1.3	1.3	0.1	0.8	57.5	7.4	17.6	11.5	0.9	0.0	0.7	12.3	4.4	18.8	0.0	0.3	5.0	24.0	34.2	0.6	2.0	23.8	10.6	47.2	1.6	13.1	6.6	44.8	2.0	2.3	4.4	0.3	1.3	32.7	10.5	1.2	59.2	61.4	129.2	0.1	9.8	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.8	0.7	0.4	0.5	1.9	0.4	0.7	0.4	86.4	91.4	3.0	135.6	101.2	0.1	0.8	298.1	2.7	63.7	40.1	0.0	2.4	26.6	54.9	0.0	1.1	102.7	23.3	19.0	43.0	9.7	42.4	5.8	520.4	2.2	20.6	10.4	6.7	9.6	0.0	0.6	5.4	20.3	1.0	72.0	0.0	67.3	73.7	1.1	68.3	0.0	0.0	7.1	0.7	12.8	200.1	209.7	4.4	66.5	356.0
SMIM11A	"C21orf51, FAM165B, SMIM11"	ENSG00000205670	"Small integral membrane protein 11A"	P58511	21	34375480-34407866	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"	8	"Alveolar cells type 1: 3.0;Ciliated cells: 4.0"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA051321: AB_2681440"	"unprognostic (2.62e-2)"	"unprognostic (4.28e-2)"			"unprognostic (1.27e-1)"		"unprognostic (5.86e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.66e-1)"	"unprognostic (3.04e-1)"		"unprognostic (4.48e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.74e-1)"		"unprognostic (8.84e-2)"	"unprognostic (4.83e-3)"	2.1	6.7	7.8	1.4	7.4	1.0	5.0	4.4	9.5	2.9	4.1			2.2	4.3	6.0	1.4	6.3	4.8	8.8	6.9	6.1	5.1	4.5	5.0	3.3	6.7		5.0	3.8	5.2	4.1	2.4		3.7	6.2		4.8	2.9	16.4	2.6	4.6	3.7	6.5	3.7	17.0	1.7			12.1		5.0	4.3	2.2	4.6	6.5	6.3	4.8	3.4	11.8	3.6	7.7	8.9	0.0	6.0	6.3	5.3	0.0	0.0	4.7	5.8	6.1	6.2	7.6	14.8	4.3	0.4	10.2	5.7	0.0	0.1	8.5	27.3	17.1	3.2	0.0	3.6	4.8	3.9	7.3	0.1	9.1	0.0	4.9	5.9	10.3	9.3	13.7	12.5	3.7	5.7	2.2	3.8	12.6	13.9	17.6	4.9	7.2	20.8	2.6	2.4	5.3	10.5	0.1	8.7	12.4	4.5	15.8	5.1	0.0	14.3	1.7	4.1	10.3	10.6	13.0	5.2	4.4	6.9	7.0	0.3	3.0	6.3	1.8	4.8	2.7	4.6	3.4	5.0	6.5	2.5	4.6	2.5	0.7	3.4	1.2	1.2	11.8	3.6											3.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	4.0	1.2	0.0	0.0	0.3	1.7	1.1	0.4	0.0	0.0	0.0	0.6	0.3	0.0	0.3	0.0	1.1	0.6	0.0	1.2	1.3	0.3	0.0	0.0	1.3	0.0	0.0	0.9	0.2	0.9	0.0	0.4	1.4	0.4	0.0	0.0	0.6	0.6	0.0	0.1	0.0	0.7	0.1
SMIM11B		ENSG00000273590	"Small integral membrane protein 11B"	Q8TCY0	21	7744962-7777853	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"blood: 19.7"	"Cell type enhanced"	"Detected in some"	16	"Alveolar cells type 1: 14.9;Ciliated cells: 20.1;Club cells: 7.9"	"Not detected"	"Not detected"							"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											HPA051321	Uncertain		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA051321: AB_2681440"					"unprognostic (1.99e-1)"					"unprognostic (1.78e-1)"				"unprognostic (1.35e-1)"				2.2	1.9		1.4		1.4	2.5		0.6	1.8	1.0			2.3	2.8	4.9	1.5	0.3	1.1	5.8			4.0	4.0	0.3	2.2			3.4	0.9	0.0		0.2		1.8	0.0		1.1	2.1	5.4	0.8	0.7	0.9		0.8	1.7	0.0			1.1		0.4	1.2		19.7	11.2	10.3	11.6	9.5	17.6	10.5	14.3	0.5	8.6	17.5	13.2	16.2	10.4	8.0	11.5	5.7	6.5	0.5	4.0	12.4	4.8	11.3	9.4	2.1	16.2	12.7	2.5	4.6	9.5	20.3	10.7	8.3	13.8	22.0	8.9	16.1	9.1	6.4	10.7	9.7	3.6	10.2	23.5	20.6	7.5	5.9	10.5	16.6	12.7	10.5	0.1	9.6	5.3	17.8	18.2	3.4	15.7	0.8	16.3	7.6	13.1	5.9	6.7	6.9	9.4	0.4	6.7	3.6	2.4	10.5	9.1	19.2	11.7	29.0	9.2	5.0	11.6	10.3	14.1	8.7	16.1	16.0	14.7	14.8	11.2	19.7	17.6	15.7	3.1	9.5	9.1	10.8	13.9	10.5											14.9	3.5	0.0	0.5	0.0	0.8	0.0	0.0	20.1	7.9	0.0	0.0	0.2	3.3	0.4	0.2	0.0	0.1	0.0	0.3	0.2	0.0	0.2	4.7	0.4	0.4	0.0	0.0	0.6	1.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.0	0.4	1.0	0.1	0.0	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.3
TMEM52B	"C12orf59, FLJ31166"	ENSG00000165685	"Transmembrane protein 52B"	Q4KMG9	12	10170542-10191801	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enriched"	"Detected in some"	23	"kidney: 85.1"	"Cell type enriched"	"Detected in some"	16	"Distal tubular cells: 603.5"	"Cancer enriched"	"Detected in some"	5	"renal cancer: 6.9"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"myeloid DC: 3.7"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	8	"CACO-2: 46.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058096	Enhanced		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA058096: AB_2683603"	"unprognostic (1.10e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.37e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (8.65e-2)"	"unprognostic (7.14e-4)"	"unprognostic (2.23e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.24e-2)"	"unprognostic (5.80e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.18e-1)"	0.1	0.0	0.1	0.1	0.6	0.9	0.1	0.1	0.6	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.2	0.1	85.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.1	2.0	0.1	0.1	0.0	0.1	0.5	0.1	0.1	0.0	0.1	0.1	0.5	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.9	3.7	1.4	1.3	0.6	0.5	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0	0.3	2.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	6.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	3.4	4.4	0.0	1.6	2.5	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	1.4	1.3	1.0	0.4	0.2	0.4	0.4	0.4	0.5	3.7	0.9	0.5	0.5	1.0	0.6	0.2	0.6	0.4	0.4	0.1	0.6	0.1	0.2	0.2	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	12.2	0.0	38.1	603.5	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.6	0.0	0.3	4.2	1.7	2.8	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.2	0.0	16.2	0.0	0.0	0.0
TNS1	"DKFZp586K0617, MXRA6, PPP1R155, TNS"	ENSG00000079308	"Tensin 1"	Q9HBL0	2	217799588-218010421	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"smooth muscle: 153.0"	"Cell type enhanced"	"Detected in many"	10	"Cardiomyocytes: 299.8;Peritubular cells: 473.8;Sertoli cells: 362.2;Smooth muscle cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"intermediate monocyte: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 46.9;ASC TERT1: 25.6;fHDF/TERT166: 22.2;REH: 24.4;TIME: 21.7"	"Low region specificity"	"Detected in all"							"CAB018774, HPA036089, HPA036090"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"CAB018774: AB_2207032, HPA036089: AB_10796111, HPA036090: AB_10794322"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (2.41e-4)"	"unprognostic (4.13e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.20e-3)"	"unprognostic (7.34e-2)"	"unprognostic (2.55e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.57e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.71e-3)"	"unprognostic (5.60e-3)"	"unprognostic (2.88e-2)"	"unprognostic (7.49e-2)"	"prognostic unfavorable (5.19e-4)"	77.6	15.6	5.2	21.1	13.7	9.2	33.5	2.9	8.9	50.0	68.9	17.2	45.6	6.0	61.1	29.8	52.0	31.1	46.7	41.0	6.8	4.8	24.0	9.2	28.9	6.1	15.8	4.1	32.3	14.1	6.0	3.8	14.0	14.3	55.1	11.4	27.6	12.8	63.4	40.8	10.1	17.2	153.0	13.7	17.0	30.0	22.6	12.2	1.5	18.3	9.8	4.0	124.6	53.6	0.2	1.0	0.9	1.7	0.0	0.0	2.9	0.0	0.1	3.0	0.0	46.9	25.6	0.3	7.9	2.6	0.4	0.3	3.4	0.0	0.0	4.6	22.2	0.5	0.5	0.3	0.4	0.2	3.1	0.2	6.7	2.0	0.9	3.5	0.0	0.8	12.1	0.0	8.5	0.0	15.3	11.1	0.0	0.2	0.8	6.6	0.9	0.0	0.4	0.3	0.0	0.1	24.4	5.9	0.3	1.6	0.0	0.7	3.5	1.3	3.4	0.8	2.2	1.1	2.4	21.7	5.7	10.4	5.8	1.7	0.4	0.0	0.0	3.3	0.9	0.4	0.0	0.4	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.9	0.0	0.7	1.0	0.0	2.9	5.2	13.7	2.9	8.9	6.8	4.8	15.8	4.1	14.3	12.2	160.8	81.8	4.6	45.8	14.3	2.7	299.8	33.1	20.1	36.4	14.0	0.0	8.0	6.6	34.4	1.7	55.0	0.0	116.8	16.8	1.1	42.2	8.9	29.0	28.8	13.3	39.7	0.0	74.3	14.9	4.3	157.1	14.6	10.1	0.0	0.0	12.6	16.8	0.0	473.8	20.9	1.4	362.2	208.1	0.7	2.0	10.3	1.6	5.3	0.0	14.9
TNS3	"FLJ13732, H_NH0549I23.2, TEM6, TENS1"	ENSG00000136205	"Tensin 3"	Q68CZ2	7	47275154-47582558	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	4	"Hofbauer cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 5.8;intermediate monocyte: 4.7;memory B-cell: 3.7;myeloid DC: 4.0;naive B-cell: 2.9;non-classical monocyte: 4.4;plasmacytoid DC: 5.6"	"Group enriched"	"Detected in many"	6	"B-cells: 3.7;dendritic cells: 5.6;monocytes: 5.8"	"Cell line enhanced"	"Detected in many"		"A549: 65.8;LHCN-M2: 42.4"	"Low region specificity"	"Detected in all"							"HPA055338, HPA056015"	Approved		Enhanced	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA055338: AB_2682789, HPA056015: AB_2683010"	"unprognostic (1.46e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.02e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.05e-1)"	"unprognostic (8.00e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.70e-1)"	"unprognostic (6.60e-2)"	"prognostic favorable (5.21e-4)"	"unprognostic (3.13e-2)"	"unprognostic (4.41e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.09e-3)"	46.9	18.5	16.4	19.3	12.7	2.8	29.8	8.1	11.7	18.2	15.7	11.4	9.1	9.9	27.4	13.9	7.7	12.3	29.6	13.5	12.1	13.2	27.3	24.9	25.1	37.7	16.0	3.6	22.4	35.5	16.4	5.5	44.9	9.6	15.0	9.3	40.3	36.4	11.7	14.9	6.7	20.7	14.7	11.6	42.7	13.9	9.6	7.8	3.8	23.8	9.6	19.9	12.5	19.3	3.7	5.6	0.8	5.8	0.1	0.2	1.8	6.3	65.8	4.0	6.9	9.2	7.5	12.8	5.8	33.4	5.7	8.8	14.7	8.6	3.2	10.4	21.2	21.5	12.2	6.4	9.5	5.2	0.0	0.4	9.0	9.5	7.8	9.5	0.0	0.1	7.4	4.1	3.3	5.2	37.5	4.5	0.0	0.0	20.3	42.4	3.9	0.0	0.2	3.8	9.2	7.9	2.9	9.8	10.7	19.8	13.1	0.4	8.2	11.5	2.3	6.4	21.1	8.8	6.7	17.9	8.9	7.1	0.1	8.9	13.1	16.9	7.6	2.2	6.3	32.2	0.2	5.8	0.0	0.1	4.7	0.2	3.7	0.0	0.0	4.0	2.9	0.0	0.0	0.8	0.1	4.4	5.6	0.0	1.8	16.4	12.7	8.1	11.7	12.1	13.2	16.0	3.6	9.6	7.8	62.5	12.0	3.7	7.3	4.2	1.4	17.3	33.1	16.0	25.0	29.6	0.0	21.4	1.7	14.4	9.5	6.9	28.0	0.0	15.8	47.3	17.5	2.8	0.0	35.1	66.7	0.0	14.5	40.5	35.8	11.8	5.8	13.7	15.1	11.8	15.6	34.2	21.0	8.6	14.5	11.5	1.4	25.8	8.2	1.7	3.4	2.9	25.1	1.9	15.3	2.1
VCL		ENSG00000035403	Vinculin	P18206	10	73995193-74121363	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	Actin-binding	"Cardiomyopathy, Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"	6	"Cardiomyocytes: 304.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 90.2;hTERT-RPE1: 88.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002131, CAB002453, HPA063777"	Enhanced		Enhanced	"Focal adhesion sites"		NA	NA		1800000000	"Focal adhesion sites"		"CAB002453: AB_564057, HPA002131: AB_1080570, HPA063777: AB_2685121"	"unprognostic (8.49e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.34e-1)"	"unprognostic (9.62e-3)"	"unprognostic (2.72e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.42e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (2.75e-4)"	"unprognostic (1.29e-1)"	"unprognostic (3.68e-2)"	"unprognostic (4.03e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.37e-3)"	31.9	7.3	4.3	19.0	6.0	8.6	24.4	5.4	5.3	37.9	41.2	6.7	24.4	8.0	72.1	29.2	36.1	27.6	44.8	35.0	4.7	3.9	20.8	6.9	25.9	9.3	3.8	5.5	29.2	12.8	18.1	7.6	22.6	9.6	43.3	18.0	20.2	14.9	38.8	59.1	14.4	20.2	113.1	3.8	23.6	23.6	29.5	3.3	3.0	15.3	20.5	11.7	73.9	26.1	3.7	12.9	21.6	11.3	2.8	9.9	15.6	22.4	15.4	27.9	19.7	35.0	40.8	15.4	29.7	90.2	20.3	23.1	13.8	19.6	1.0	24.8	51.8	13.9	28.9	18.3	14.9	21.5	1.9	7.8	10.7	15.0	5.7	19.2	2.1	16.4	33.7	4.0	27.5	25.1	88.6	27.1	1.8	7.7	2.2	33.8	3.8	0.3	2.5	13.2	10.8	54.5	3.7	14.6	2.8	29.1	29.1	1.0	4.1	16.5	18.7	8.5	25.7	8.6	3.2	36.2	22.2	9.3	10.7	27.7	0.4	0.9	4.4	25.9	6.0	6.2	8.5	7.6	21.6	9.9	10.8	7.0	3.7	4.7	5.1	12.9	1.6	1.8	3.6	7.0	2.8	11.3	5.0	1.2	15.6	4.3	6.0	5.4	5.3	4.7	3.9	3.8	5.5	9.6	3.3	92.3	37.8	11.5	94.3	102.0	13.5	304.7	50.9	28.1	77.3	40.1	80.5	44.5	3.3	59.0	2.3	54.3	61.0	0.0	53.1	67.5	69.7	88.5	33.6	30.6	21.4	15.9	36.8	73.1	36.2	4.7	46.3	28.0	25.3	9.0	29.5	12.2	85.6	31.9	72.2	12.4	35.2	103.5	102.7	14.2	10.9	81.3	33.2	19.8	37.5	76.0
VIPR2	"VPAC2, VPAC2R"	ENSG00000106018	"Vasoactive intestinal peptide receptor 2"	P41587	7	159028175-159144957	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Muller glia cells: 32.3;Rod photoreceptor cells: 44.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.8"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	16	"plasmacytoid DC: 13.1"	"Lineage enriched"	"Detected in single"	16	"dendritic cells: 13.1"	"Cell line enhanced"	"Detected in some"		"HeLa: 4.2;HMC-1: 6.5;MOLT-4: 8.8;U-266/70: 29.8"	"Region enhanced"	"Detected in some"		"olfactory region: 33.2"	"Low region specificity"	"Detected in all"			HPA062707	Approved		Approved	"Focal adhesion sites"		NA	NA			"Focal adhesion sites"		"HPA062707: AB_2684842"	"unprognostic (3.65e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.89e-2)"	9.6	1.2	2.1	2.9	1.3	0.6	2.1	0.9	10.2	18.0	10.6	1.5	14.1	2.1	11.5	14.3	3.1	3.3	4.7	13.3	2.6	1.8	1.0	0.6	0.6	3.0	1.9	2.3	10.8	15.7	0.3	2.6	6.4	2.1	8.4	1.5	4.9	1.1	24.0	7.3	0.6	3.9	7.1	2.4	1.1	8.3	2.4	1.1	16.9	0.4	0.7	0.8	5.7	9.9	0.0	13.1	0.1	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.2	8.8	0.0	0.7	0.0	0.0	2.2	0.1	0.5	0.0	0.0	2.1	1.7	0.1	0.1	0.0	0.2	0.0	0.5	0.0	0.0	0.3	0.0	0.0	29.8	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.1	0.2	0.1	0.0	0.0	13.1	0.0	0.1	2.1	1.3	0.9	10.2	2.6	1.8	1.9	2.3	2.1	1.1	0.0	0.0	0.0	2.2	0.6	1.4	6.7	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	5.8	0.0	1.5	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	9.5	0.0	1.7	0.0	0.0	32.3	0.8	0.0	2.5	0.3	44.5	0.0	8.0	3.7	2.1	0.0	0.0	2.9	0.0	0.1
